HighTower Advisors LLC Boosts Stock Position in Sanofi (NASDAQ:SNY)

HighTower Advisors LLC grew its holdings in shares of Sanofi (NASDAQ:SNY) by 3.4% in the fourth quarter, Holdings Channel reports. The institutional investor owned 91,071 shares of the company’s stock after purchasing an additional 2,971 shares during the period. HighTower Advisors LLC’s holdings in Sanofi were worth $4,392,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Synergy Asset Management LLC purchased a new position in shares of Sanofi in the 4th quarter valued at $25,000. McClarren Financial Advisors Inc. grew its holdings in shares of Sanofi by 952.6% during the fourth quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company’s stock worth $28,000 after purchasing an additional 543 shares during the last quarter. Sunbelt Securities Inc. increased its position in shares of Sanofi by 72.1% during the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock worth $43,000 after purchasing an additional 313 shares in the last quarter. Sierra Ocean LLC purchased a new stake in shares of Sanofi in the 4th quarter valued at about $44,000. Finally, Versant Capital Management Inc acquired a new stake in shares of Sanofi in the 4th quarter valued at about $54,000. 14.04% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on SNY. StockNews.com downgraded Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th. Deutsche Bank Aktiengesellschaft upgraded shares of Sanofi from a “sell” rating to a “hold” rating in a research note on Thursday, January 30th. Finally, Sanford C. Bernstein raised shares of Sanofi to a “strong-buy” rating in a report on Thursday, January 30th. Two analysts have rated the stock with a hold rating, one has issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $60.00.

Sanofi Trading Down 0.9 %

Shares of SNY stock opened at $58.60 on Thursday. Sanofi has a twelve month low of $45.22 and a twelve month high of $60.12. The company has a current ratio of 1.46, a quick ratio of 1.14 and a debt-to-equity ratio of 0.15. The business’s 50 day moving average is $54.22 and its two-hundred day moving average is $52.89. The company has a market capitalization of $148.72 billion, a P/E ratio of 23.53, a price-to-earnings-growth ratio of 1.01 and a beta of 0.58.

Sanofi (NASDAQ:SNY) last announced its quarterly earnings data on Thursday, January 30th. The company reported $0.70 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. Equities analysts forecast that Sanofi will post 4.36 EPS for the current year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.